Cargando…
Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals
In recent months, four different systems have been reported in the literature in which CCN2 transgenes were individually expressed in podocytes, hepatocytes, cardiomyocytes or respiratory epithelial cells to achieve overexpression in, respectively, the kidney, liver, heart, or lung. These transgenic...
Autor principal: | Brigstock, David R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821473/ https://www.ncbi.nlm.nih.gov/pubmed/19798591 http://dx.doi.org/10.1007/s12079-009-0071-5 |
Ejemplares similares
-
Driving fibrosis in neuromuscular diseases: Role and regulation of Connective tissue growth factor (CCN2/CTGF)
por: Rebolledo, Daniela L., et al.
Publicado: (2021) -
Connective Tissue Growth Factor (CTGF/CCN2) Is Negatively Regulated during Neuron-Glioblastoma Interaction
por: Romão, Luciana F., et al.
Publicado: (2013) -
Anti-connective tissue growth factor (CTGF/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis
por: Makino, Katsunari, et al.
Publicado: (2017) -
Development of Normal and Cleft Palate: A Central Role for Connective Tissue Growth Factor (CTGF)/CCN2
por: Tarr, Joseph T., et al.
Publicado: (2018) -
Antiproliferative factor regulates connective tissue growth factor (CTGF/CCN2) expression in T24 bladder carcinoma cells
por: Matika, Christina A., et al.
Publicado: (2012)